109 related articles for article (PubMed ID: 24449825)
41. Accumulation of DNA methylation is associated with tumor stage in gastric cancer.
Oue N; Mitani Y; Motoshita J; Matsumura S; Yoshida K; Kuniyasu H; Nakayama H; Yasui W
Cancer; 2006 Mar; 106(6):1250-9. PubMed ID: 16475210
[TBL] [Abstract][Full Text] [Related]
42. Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma.
Tannapfel A; Sommerer F; Benicke M; Weinans L; Katalinic A; Geissler F; Uhlmann D; Hauss J; Wittekind C
J Pathol; 2002 Aug; 197(5):624-31. PubMed ID: 12210082
[TBL] [Abstract][Full Text] [Related]
43. Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma.
Chinnasri P; Pairojkul C; Jearanaikoon P; Sripa B; Bhudhisawasdi V; Tantimavanich S; Limpaiboon T
Hum Pathol; 2009 Jun; 40(6):817-26. PubMed ID: 19200577
[TBL] [Abstract][Full Text] [Related]
44. Low frequency of p16/CDKN2A methylation in sporadic melanoma: comparative approaches for methylation analysis of primary tumors.
Gonzalgo ML; Bender CM; You EH; Glendening JM; Flores JF; Walker GJ; Hayward NK; Jones PA; Fountain JW
Cancer Res; 1997 Dec; 57(23):5336-47. PubMed ID: 9393758
[TBL] [Abstract][Full Text] [Related]
45. Ras association domain family 1A: a promising prognostic marker in recurrent nonmuscle invasive bladder cancer.
Kim JS; Chae Y; Ha YS; Kim IY; Byun SS; Yun SJ; Kim WJ
Clin Genitourin Cancer; 2012 Jun; 10(2):114-20. PubMed ID: 22382007
[TBL] [Abstract][Full Text] [Related]
46. Codeletion of CDKN2 and MTAP genes in a subset of non-Hodgkin's lymphoma may be associated with histologic transformation from low-grade to diffuse large-cell lymphoma.
Dreyling MH; Roulston D; Bohlander SK; Vardiman J; Olopade OI
Genes Chromosomes Cancer; 1998 May; 22(1):72-8. PubMed ID: 9591637
[TBL] [Abstract][Full Text] [Related]
47. Loss of p16/INK4A protein expression in non-Hodgkin's lymphomas is a frequent finding associated with tumor progression.
Villuendas R; Sánchez-Beato M; Martínez JC; Saez AI; Martinez-Delgado B; García JF; Mateo MS; Sanchez-Verde L; Benítez J; Martínez P; Piris MA
Am J Pathol; 1998 Sep; 153(3):887-97. PubMed ID: 9736037
[TBL] [Abstract][Full Text] [Related]
48. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K
Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757
[TBL] [Abstract][Full Text] [Related]
49. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases.
Ai L; Stephenson KK; Ling W; Zuo C; Mukunyadzi P; Suen JY; Hanna E; Fan CY
Mod Pathol; 2003 Sep; 16(9):944-50. PubMed ID: 13679459
[TBL] [Abstract][Full Text] [Related]
50. Quantification of DAPK1 promoter methylation in bone marrow and peripheral blood as a follicular lymphoma biomarker.
Giachelia M; Bozzoli V; D'Alò F; Tisi MC; Massini G; Maiolo E; Guidi F; Cupelli E; Martini M; Larocca LM; Voso MT; Leone G; Hohaus S
J Mol Diagn; 2014 Jul; 16(4):467-76. PubMed ID: 24814955
[TBL] [Abstract][Full Text] [Related]
51. Follicular lymphoma: 2020 update on diagnosis and management.
Freedman A; Jacobsen E
Am J Hematol; 2020 Mar; 95(3):316-327. PubMed ID: 31814159
[TBL] [Abstract][Full Text] [Related]
52. Abundant expression of BMI1 in follicular lymphoma is associated with reduced overall survival.
AlJohani N; Choi SJ; Day AG; Alhejaily A; Virk S; Baetz T; LeBrun DP
Leuk Lymphoma; 2018 Sep; 59(9):2211-2219. PubMed ID: 29251058
[TBL] [Abstract][Full Text] [Related]
53. BIM deletion polymorphism accounts for lack of favorable outcome in Japanese females with follicular lymphoma.
Ito Y; Umezu T; Tadokoro K; Saito Y; Katagiri S; Suguro T; Asano M; Yoshizawa S; Akahane D; Tanaka Y; Fujimoto H; Okabe S; Gotoh M; Tauchi T; Kawana C; Ohyashiki JH; Nakamura N; Ohyashiki K
Leuk Lymphoma; 2019 May; 60(5):1283-1288. PubMed ID: 30480474
[TBL] [Abstract][Full Text] [Related]
54. Absence of methylation-dependent transcriptional silencing in TP73 irrespective of the methylation status of the CDKN2A CpG island in plasma cell neoplasia.
Hatzimichael E; Benetatos L; Dasoula A; Dranitsaris G; Tsiara S; Georgiou I; Syrrou M; Stebbing J; Coley HM; Crook T; Bourantas KL
Leuk Res; 2009 Sep; 33(9):1272-5. PubMed ID: 19423161
[TBL] [Abstract][Full Text] [Related]
55.
Hayashi T; Shibata T; Nakamura M; Sakurai N; Takano H; Ota M; Nomura-Horita T; Hayashi R; Shimasaki T; Ostuka T; Tahara T; Arisawa T
Genet Test Mol Biomarkers; 2021 Apr; 25(4):255-262. PubMed ID: 33877894
[No Abstract] [Full Text] [Related]
56. Polymorphisms in DNA repair and one-carbon metabolism genes and overall survival in diffuse large B-cell lymphoma and follicular lymphoma.
Wang SS; Maurer MJ; Morton LM; Habermann TM; Davis S; Cozen W; Lynch CF; Severson RK; Rothman N; Chanock SJ; Hartge P; Cerhan JR
Leukemia; 2009 Mar; 23(3):596-602. PubMed ID: 18830263
[No Abstract] [Full Text] [Related]
57. m7FLIPI and targeted sequencing in high-risk follicular lymphoma.
Sorigue M; Oliveira A; Mercadal S; Tapia G; Climent F; Perez-Roca L; Lorences I; Domingo-Domenech E; Cabezon M; Navarro JT; Gonzalez-Barca E; Zamora L; Ribera JM; Sureda A; Armengol MP; Sancho JM
Hematol Oncol; 2019 Dec; 37(5):564-568. PubMed ID: 31475375
[TBL] [Abstract][Full Text] [Related]
58. Genetics of follicular lymphoma transformation.
Pasqualucci L; Khiabanian H; Fangazio M; Vasishtha M; Messina M; Holmes AB; Ouillette P; Trifonov V; Rossi D; Tabbò F; Ponzoni M; Chadburn A; Murty VV; Bhagat G; Gaidano G; Inghirami G; Malek SN; Rabadan R; Dalla-Favera R
Cell Rep; 2014 Jan; 6(1):130-40. PubMed ID: 24388756
[TBL] [Abstract][Full Text] [Related]
59. p16 Tumor Suppressor Gene Methylation in Diffuse Large B Cell Lymphoma: A Study of 88 Cases at Two Hospitals in the East Coast of Malaysia.
Mohd Ridah LJ; A Talib N; Muhammad N; Hussain FA; Zainuddin N
Asian Pac J Cancer Prev; 2017 Oct; 18(10):2781-2785. PubMed ID: 29072413
[TBL] [Abstract][Full Text] [Related]
60. Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival.
Cerhan JR; Wang S; Maurer MJ; Ansell SM; Geyer SM; Cozen W; Morton LM; Davis S; Severson RK; Rothman N; Lynch CF; Wacholder S; Chanock SJ; Habermann TM; Hartge P
Blood; 2007 Jun; 109(12):5439-46. PubMed ID: 17327408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
